Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
Condition:   Type 1 Diabetes Interventions:   Drug: Empagliflozin;   Drug: Placebo Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Diabetes Canada Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials